Parkinson's disease Flashcards

1
Q

What is the epidemiology of Parkinson’s?

A

Age of onset – 45-65

2nd most common neurodegenerative disease (after Alzheimer’s)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the aetiology of Parkinson’s?

A

Most commonly caused by idiopathic Parkinson’s disease

Others:
Can be other rare genetic syndromes 
Certain drugs – neuroleptics, metoclopramide, prochlorperazine 
Trauma/boxing 
Encephalopathy post flu 
Manganese/copper toxicity – Wilsons 
HIV
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the pathophysiology of Parkinson’s?

A

Result of a loss of domaminergic neruons in the basal ganglia (substantia nigra)

Surviving neurons contain aggregations of protein (α-synuclein) called Lewy bodies

Sometimes these present throughout the brain and in such instances, Lewy Body dementia often co-occurs (whether its classified as dementia with Parkinson’s or Parkinson’s with dementia depends on which presents first)

Symptoms are exhibited once neuron levels are 20-40% of the normal

The degree of cell loss and akinesia are strongly correlated

There is no obvious cause for the loss in neurons

The disease progresses slowly and without remission

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the classic triad of symptoms in Parkinson’s?

A

Tremor – usually of the hands ‘pill-rolling’ , 4-7Hz, disappears with deliberate activity/worse at rest

Rigidity – increased resistance to passive movement that is equal throughout the range of movement (unlike spasticity which is velocity dependent); equal in extensors and flexors; power remains normal and there is no sensory loss

Bradykinesia – slow movements, especially exaggerated in fine movements – touch finger to thumb

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are some other symptoms of Parkinson’s?

A

Posture + gait – slow shuffling steps, often stooped with reduced arm swinging

Speech – may be slow and monotonous; may be slurred or absent in late stage

Plain/blank face – exaggerated by low blink rate

Depression, Dementia

Constipation, frequency/urgency

Hallucinations

Poor decoding of emotional content of speech

REM sleep disorders

Reduced sense of smell

Micrographia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How do you diagnose Parkinson’s?

A

Usually completely clinical

Can do ioflupane SPECT scan = DaTSCAN:
Looking at dopaminergic neurons in substantia nigra can be used to identify degeneration

SN usually look like comas – in degeneration will look like dots or much reduced

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the mainstay of Parkinson’s treatment?

A

L-DOPA:

Dopamine cannot cross BBB but precursor L-DOPA can → converted to dopamine in brain → increases levels
Often given with other agents i.e. dopa-decarboxylase inhibitors, used to prolong its short half-life and extend its effects = Co-beneldopa, co-careldopa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is important to note when treating with L-DOPA?

A

Therapeutic window = narrow:
Can easily give too much and get side effects (e.g. hypotension, nausea, psychotic symptoms) or too little and under treat

This leads to an ‘on-off effect’:
From the fluctuating plasma concentration

Window narrows further over 10-15yrs of treatment as efficacy decreases too (hence given with dopa-decarboxylase inhibitors), delay treatment until necessary

Do not stop suddenly as can precipitate neuroleptic malignant syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are some other agents given in Parkinson’s?

A

Ropinirole and Pramipexole:

i) Selective D3 agonists
ii) Often used as adjuncts to L-DOPA

Bromocriptine and amantadine:

i) Dopamine agonists
ii) Rotigotine – available as patch and useful for NBM

Selegilene:

i) MAO-B inhibitors
ii) Useful adjunct

Catechol-O-methyl transferase (COMT) inhibitors:
i) Inhibit breakdown of levodopa, increase its half life and so helps with end of dose titrations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What other management is required in Parkinson’s?

A

Detailed review of care and Dx every 6-12/12 - tackle any new features properly (i.e. DLB)

Medicines reviews frequently

Written info - disease + drugs (e.g. Parkinsons.org.uk)

Advise them to inform DVLA

Advance directives + LPA

Vit D supplementation (due to seditary life and increased falls risk)

MDT specialist care - SALT, PT, OT, dietetics, social care, community nursing, continence + urology, psychology - as required

Carer support

Atypical antipsychotics (if necessary) - olanzapine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What conditions are associated with PD?

A

Parkinson plus syndromes:

Progressive Supranuclear Palsy:
Early postural instability and falls, vertical gaze palsy, rigidity of trunk>limbs, no tremor
(PD + gaze palsy = PSP)

Multiple System Atrophy:
Early/simultaneous autonomic features (postural hypotension, bladder dysfunction, ED) and cerebellar signs
(PD + autonomic features at same time = MSA)
Hot cross bun sign = cross shape on pons

DLB:
Cognitive decline, fluctuating cognitive impairment and hallucinations - before/very early in PD progression

Poor responses to levodopa, generally pretty sad

How well did you know this?
1
Not at all
2
3
4
5
Perfectly